Novel electronic biosensor for automated inoculum preparation to accelerate antimicrobial susceptibility testing

Abstract A key predictor of morbidity and mortality for patients with a bloodstream infection is time to appropriate antimicrobial therapy. Accelerating antimicrobial susceptibility testing from positive blood cultures is therefore key to improving patient outcomes, yet traditional laboratory approa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Suzanne Putney, Andrew H. Theiss, Nitin K. Rajan, Eszter Deak, Creighton Buie, Yvonne Ngo, Hima Shah, Victoria Yuan, Elizabeth Botbol-Ponte, Adrian Hoyos-Urias, Oren Knopfmacher, Catherine A. Hogan, Niaz Banaei, Meike S. Herget
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3a0d158affe14e59898388fa93ad2ee1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3a0d158affe14e59898388fa93ad2ee1
record_format dspace
spelling oai:doaj.org-article:3a0d158affe14e59898388fa93ad2ee12021-12-02T17:51:21ZNovel electronic biosensor for automated inoculum preparation to accelerate antimicrobial susceptibility testing10.1038/s41598-021-90830-22045-2322https://doaj.org/article/3a0d158affe14e59898388fa93ad2ee12021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-90830-2https://doaj.org/toc/2045-2322Abstract A key predictor of morbidity and mortality for patients with a bloodstream infection is time to appropriate antimicrobial therapy. Accelerating antimicrobial susceptibility testing from positive blood cultures is therefore key to improving patient outcomes, yet traditional laboratory approaches can require 2–4 days for actionable results. The eQUANT—a novel instrument utilizing electrical biosensors—produces a standardized inoculum equivalent to a 0.5 McFarland directly from positive blood cultures. This proof-of-concept study demonstrates that eQUANT inocula prepared from clinically significant species of Enterobacterales were comparable to 0.5 McF inocula generated from bacterial colonies in both CFU/ml concentration and performance in antimicrobial susceptibility testing, with ≥ 95% essential and categorical agreement for VITEK2 and disk diffusion. The eQUANT, combined with a rapid, direct from positive blood culture identification technique, can allow the clinical laboratory to begin antimicrobial susceptibility testing using a standardized inoculum approximately 2–3 h after a blood culture flags positive. This has the potential to improve clinical practice by accelerating conventional antimicrobial susceptibility testing and the resulting targeted antibiotic therapy.Suzanne PutneyAndrew H. TheissNitin K. RajanEszter DeakCreighton BuieYvonne NgoHima ShahVictoria YuanElizabeth Botbol-PonteAdrian Hoyos-UriasOren KnopfmacherCatherine A. HoganNiaz BanaeiMeike S. HergetNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Suzanne Putney
Andrew H. Theiss
Nitin K. Rajan
Eszter Deak
Creighton Buie
Yvonne Ngo
Hima Shah
Victoria Yuan
Elizabeth Botbol-Ponte
Adrian Hoyos-Urias
Oren Knopfmacher
Catherine A. Hogan
Niaz Banaei
Meike S. Herget
Novel electronic biosensor for automated inoculum preparation to accelerate antimicrobial susceptibility testing
description Abstract A key predictor of morbidity and mortality for patients with a bloodstream infection is time to appropriate antimicrobial therapy. Accelerating antimicrobial susceptibility testing from positive blood cultures is therefore key to improving patient outcomes, yet traditional laboratory approaches can require 2–4 days for actionable results. The eQUANT—a novel instrument utilizing electrical biosensors—produces a standardized inoculum equivalent to a 0.5 McFarland directly from positive blood cultures. This proof-of-concept study demonstrates that eQUANT inocula prepared from clinically significant species of Enterobacterales were comparable to 0.5 McF inocula generated from bacterial colonies in both CFU/ml concentration and performance in antimicrobial susceptibility testing, with ≥ 95% essential and categorical agreement for VITEK2 and disk diffusion. The eQUANT, combined with a rapid, direct from positive blood culture identification technique, can allow the clinical laboratory to begin antimicrobial susceptibility testing using a standardized inoculum approximately 2–3 h after a blood culture flags positive. This has the potential to improve clinical practice by accelerating conventional antimicrobial susceptibility testing and the resulting targeted antibiotic therapy.
format article
author Suzanne Putney
Andrew H. Theiss
Nitin K. Rajan
Eszter Deak
Creighton Buie
Yvonne Ngo
Hima Shah
Victoria Yuan
Elizabeth Botbol-Ponte
Adrian Hoyos-Urias
Oren Knopfmacher
Catherine A. Hogan
Niaz Banaei
Meike S. Herget
author_facet Suzanne Putney
Andrew H. Theiss
Nitin K. Rajan
Eszter Deak
Creighton Buie
Yvonne Ngo
Hima Shah
Victoria Yuan
Elizabeth Botbol-Ponte
Adrian Hoyos-Urias
Oren Knopfmacher
Catherine A. Hogan
Niaz Banaei
Meike S. Herget
author_sort Suzanne Putney
title Novel electronic biosensor for automated inoculum preparation to accelerate antimicrobial susceptibility testing
title_short Novel electronic biosensor for automated inoculum preparation to accelerate antimicrobial susceptibility testing
title_full Novel electronic biosensor for automated inoculum preparation to accelerate antimicrobial susceptibility testing
title_fullStr Novel electronic biosensor for automated inoculum preparation to accelerate antimicrobial susceptibility testing
title_full_unstemmed Novel electronic biosensor for automated inoculum preparation to accelerate antimicrobial susceptibility testing
title_sort novel electronic biosensor for automated inoculum preparation to accelerate antimicrobial susceptibility testing
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/3a0d158affe14e59898388fa93ad2ee1
work_keys_str_mv AT suzanneputney novelelectronicbiosensorforautomatedinoculumpreparationtoaccelerateantimicrobialsusceptibilitytesting
AT andrewhtheiss novelelectronicbiosensorforautomatedinoculumpreparationtoaccelerateantimicrobialsusceptibilitytesting
AT nitinkrajan novelelectronicbiosensorforautomatedinoculumpreparationtoaccelerateantimicrobialsusceptibilitytesting
AT eszterdeak novelelectronicbiosensorforautomatedinoculumpreparationtoaccelerateantimicrobialsusceptibilitytesting
AT creightonbuie novelelectronicbiosensorforautomatedinoculumpreparationtoaccelerateantimicrobialsusceptibilitytesting
AT yvonnengo novelelectronicbiosensorforautomatedinoculumpreparationtoaccelerateantimicrobialsusceptibilitytesting
AT himashah novelelectronicbiosensorforautomatedinoculumpreparationtoaccelerateantimicrobialsusceptibilitytesting
AT victoriayuan novelelectronicbiosensorforautomatedinoculumpreparationtoaccelerateantimicrobialsusceptibilitytesting
AT elizabethbotbolponte novelelectronicbiosensorforautomatedinoculumpreparationtoaccelerateantimicrobialsusceptibilitytesting
AT adrianhoyosurias novelelectronicbiosensorforautomatedinoculumpreparationtoaccelerateantimicrobialsusceptibilitytesting
AT orenknopfmacher novelelectronicbiosensorforautomatedinoculumpreparationtoaccelerateantimicrobialsusceptibilitytesting
AT catherineahogan novelelectronicbiosensorforautomatedinoculumpreparationtoaccelerateantimicrobialsusceptibilitytesting
AT niazbanaei novelelectronicbiosensorforautomatedinoculumpreparationtoaccelerateantimicrobialsusceptibilitytesting
AT meikesherget novelelectronicbiosensorforautomatedinoculumpreparationtoaccelerateantimicrobialsusceptibilitytesting
_version_ 1718379279442509824